150 results
6-K
EX-99.1
TRIB
Trinity Biotech Plc
5 Apr 24
Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023
1:05pm
of sales
Gross profit
Gross margin %
Other operating income
Research & development expenses
Selling, general and administrative expenses
Impairment … in Q4, 2022 was comprised of government grants in relation to R&D activities and there were no equivalent grants in Q4, 2023.
R&D and SG&A
Research
6-K
EX-99.1
TRIB
Trinity Biotech Plc
1 Feb 24
LifeSci Partners, LLC
11:37am
services agreement with the acquirers of Fitzgerald Industries.
Research and development expenses of $1.2 million in Q3, 2023 increased from $1.0 … $’000
(unaudited)
Revenues
Cost of sales
Gross profit
Gross margin %
Other operating income
Research & development expenses
Selling, general
6-K
EX-99.1
TRIB
Trinity Biotech Plc
2 Jan 24
Trinity Biotech Announces It Has Begun Shipments of Its New
2:02pm
to, the results of research and development efforts, the effect of regulation by the U.S. Food and Drug Administration and other agencies, the impact
6-K
EX-99.1
TRIB
Trinity Biotech Plc
19 Dec 23
Trinity Biotech Announces Management Changes
1:56pm
, but not limited to, the results of research and development efforts, the effect of regulation by the U.S. Food and Drug Administration and other agencies
6-K
EX-99.1
zsirvken
29 Nov 23
Trinity Biotech Receives Non-Compliance Notice Regarding
9:00am
6-K
EX-99.1
svju3btprm2in09j426
6 Oct 23
Trinity Biotech Announces Q2 2023 Financial Results
4:05pm
6-K
EX-99.1
ctotjsr99xiqfi8s48x1
12 Sep 23
Trinity Biotech Receives Non-Compliance Notice Regarding
4:04pm
6-K
EX-99.1
onb3m0 r130j
6 Sep 23
This report has been prepared in accordance with the Irish Companies Act 2014
4:04pm
6-K
EX-99.1
gcuou736y 1b
10 Jul 23
Trinity Biotech Announces Q1 2023 Financial Results
6:02am
6-K
EX-99.1
mutd4 obpg9
8 May 23
Current report (foreign)
9:04am
6-K
EX-99.1
2kj lzj12f2cdake
1 May 23
Current report (foreign)
1:43pm
6-K
EX-99.1
fcve4x55dhiw pb
25 Apr 23
Trinity Biotech Receives Non-Compliance Notice Regarding
4:40pm
6-K
EX-99.1
rd6yzof0d 6fh
24 Apr 23
First Amendment to Amended and Restated Credit Agreement and Guaranty
7:26am
6-K
EX-4.15
f0y83awx6qbz5 csuw
24 Apr 23
First Amendment to Amended and Restated Credit Agreement and Guaranty
7:26am
6-K
EX-99.1
eawhe4dsqsy oz
16 Dec 22
Trinity Biotech Announces Q3 2022 Financial Results
10:59am
6-K
EX-99.1
hra ga52oze
9 Dec 22
Trinity Biotech plc to Announce Third Quarter Fiscal Year 2022 Financial Results
10:52am
6-K
EX-99.1
ctaf6t9nxwzd2jsxzj
15 Nov 22
Current report (foreign)
4:05pm